ABT vs SMP · P/E 25, rev $44.33B vs P/E 10, rev $952.8M
Abbott Laboratories (ABT) versus Standard Motor Products Inc (SMP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Standard Motor Products Inc (SMP) is a auto parts company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported SMP revenue for 2026-06-30 was $952.8M. Net income was $47.5M. SMP currently screens at market cap $850.2M and trailing P/E 10.3.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. SMP currently screens at market cap $850.2M and trailing P/E 10.3.
Not investment advice. Open the ABT and SMP stock pages for the full models.
Not investment advice.